156 related articles for article (PubMed ID: 16479255)
1. Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen.
Kohno Y; Matsuki Y; Tanimoto A; Izumi H; Uchiumi T; Kohno K; Shimajiri S; Sasaguri Y
Br J Cancer; 2006 Mar; 94(5):710-6. PubMed ID: 16479255
[TBL] [Abstract][Full Text] [Related]
2. Expression and cellular localization of dbpC/Contrin in germ cell tumor cell lines.
Yoshida T; Izumi H; Uchiumi T; Sasaguri Y; Tanimoto A; Matsumoto T; Naito S; Kohno K
Biochim Biophys Acta; 2006; 1759(1-2):80-8. PubMed ID: 16624424
[TBL] [Abstract][Full Text] [Related]
3. Occurrence of seminoma and dysgerminoma in father and daughter.
Yule SM; Dawes PJ; Malcolm AJ; Pearson AD
Pediatr Hematol Oncol; 1994; 11(2):211-3. PubMed ID: 8204448
[TBL] [Abstract][Full Text] [Related]
4. Contrin, the human homologue of a germ-cell Y-box-binding protein: cloning, expression, and chromosomal localization.
Tekur S; Pawlak A; Guellaen G; Hecht NB
J Androl; 1999; 20(1):135-44. PubMed ID: 10100484
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of c-KIT mutations in gonadoblastoma and dysgerminomas of patients with disorders of sex development (DSD) and ovarian dysgerminomas.
Hersmus R; Stoop H; van de Geijn GJ; Eini R; Biermann K; Oosterhuis JW; Dhooge C; Schneider DT; Meijssen IC; Dinjens WN; Dubbink HJ; Drop SL; Looijenga LH
PLoS One; 2012; 7(8):e43952. PubMed ID: 22937135
[TBL] [Abstract][Full Text] [Related]
6. AZFa protein DDX3Y is differentially expressed in human male germ cells during development and in testicular tumours: new evidence for phenotypic plasticity of germ cells.
Gueler B; Sonne SB; Zimmer J; Hilscher B; Hilscher W; Græm N; Rajpert-De Meyts E; Vogt PH
Hum Reprod; 2012 Jun; 27(6):1547-55. PubMed ID: 22466863
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein signalling activity distinguishes histological subsets of paediatric germ cell tumours.
Fustino N; Rakheja D; Ateek CS; Neumann JC; Amatruda JF
Int J Androl; 2011 Aug; 34(4 Pt 2):e218-33. PubMed ID: 21696393
[TBL] [Abstract][Full Text] [Related]
8. The cancer/testis-antigen PRAME supports the pluripotency network and represses somatic and germ cell differentiation programs in seminomas.
Nettersheim D; Arndt I; Sharma R; Riesenberg S; Jostes S; Schneider S; Hölzel M; Kristiansen G; Schorle H
Br J Cancer; 2016 Aug; 115(4):454-64. PubMed ID: 27441500
[TBL] [Abstract][Full Text] [Related]
9. Novel germ cell markers characterize testicular seminoma and fetal testis.
Gashaw I; Dushaj O; Behr R; Biermann K; Brehm R; Rübben H; Grobholz R; Schmid KW; Bergmann M; Winterhager E
Mol Hum Reprod; 2007 Oct; 13(10):721-7. PubMed ID: 17785371
[TBL] [Abstract][Full Text] [Related]
10. Repression of major histocompatibility complex I-A beta gene expression by dbpA and dbpB (mYB-1) proteins.
Lloberas J; Maki RA; Celada A
Mol Cell Biol; 1995 Sep; 15(9):5092-9. PubMed ID: 7651426
[TBL] [Abstract][Full Text] [Related]
11. Chromosome X-encoded cancer/testis antigens show distinctive expression patterns in developing gonads and in testicular seminoma.
Chen YT; Chiu R; Lee P; Beneck D; Jin B; Old LJ
Hum Reprod; 2011 Dec; 26(12):3232-43. PubMed ID: 22016418
[TBL] [Abstract][Full Text] [Related]
12. Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma.
Lau Y; Chou P; Iezzoni J; Alonzo J; Kömüves L
Cytogenet Cell Genet; 2000; 91(1-4):160-4. PubMed ID: 11173850
[TBL] [Abstract][Full Text] [Related]
13. Regenerating I messenger RNA and protein expression in the failing human testis: a potential molecular prognostic marker of seminoma.
Mauro V; Volle DH; Chevallier D; Haudebourg J; Sénégas-Balas F; Pointis G
Hum Pathol; 2011 Dec; 42(12):1841-8. PubMed ID: 21683984
[TBL] [Abstract][Full Text] [Related]
14. Predicting metastasized seminoma using gene expression.
Ruf CG; Linbecker M; Port M; Riecke A; Schmelz HU; Wagner W; Meineke V; Abend M
BJU Int; 2012 Jul; 110(2 Pt 2):E14-20. PubMed ID: 22243760
[TBL] [Abstract][Full Text] [Related]
15. KIT mutations are common in testicular seminomas.
Kemmer K; Corless CL; Fletcher JA; McGreevey L; Haley A; Griffith D; Cummings OW; Wait C; Town A; Heinrich MC
Am J Pathol; 2004 Jan; 164(1):305-13. PubMed ID: 14695343
[TBL] [Abstract][Full Text] [Related]
16. Genomic and expression profiling of human spermatocytic seminomas: primary spermatocyte as tumorigenic precursor and DMRT1 as candidate chromosome 9 gene.
Looijenga LH; Hersmus R; Gillis AJ; Pfundt R; Stoop HJ; van Gurp RJ; Veltman J; Beverloo HB; van Drunen E; van Kessel AG; Pera RR; Schneider DT; Summersgill B; Shipley J; McIntyre A; van der Spek P; Schoenmakers E; Oosterhuis JW
Cancer Res; 2006 Jan; 66(1):290-302. PubMed ID: 16397242
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor-beta expression in human testicular germ cell tumors.
Pais V; Leav I; Lau KM; Jiang Z; Ho SM
Clin Cancer Res; 2003 Oct; 9(12):4475-82. PubMed ID: 14555521
[TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue.
Yuasa T; Okamoto K; Kawakami T; Mishina M; Ogawa O; Okada Y
J Urol; 2001 May; 165(5):1790-4. PubMed ID: 11342977
[TBL] [Abstract][Full Text] [Related]
19. Ovarian dysgerminomas are characterised by frequent KIT mutations and abundant expression of pluripotency markers.
Hoei-Hansen CE; Kraggerud SM; Abeler VM; Kaern J; Rajpert-De Meyts E; Lothe RA
Mol Cancer; 2007 Feb; 6():12. PubMed ID: 17274819
[TBL] [Abstract][Full Text] [Related]
20. The emerging phenotype of the testicular carcinoma in situ germ cell.
Rajpert-De Meyts E; Bartkova J; Samson M; Hoei-Hansen CE; Frydelund-Larsen L; Bartek J; Skakkebaek NE
APMIS; 2003 Jan; 111(1):267-78; discussion 278-9. PubMed ID: 12752272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
